Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Heart Vessels ; 30(4): 469-76, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24691699

RESUMO

Postprandial hyperglycemia is a risk factor for cardiovascular disease and mortality. Serum 1,5-anhydroglucitol (1,5-AG) level is an useful clinical marker of glucose metabolism which reflects postprandial hyperglycemia more robustly compared to hemoglobin A1c (HbA1c). Relationship between serum 1,5-AG level and cardiovascular disease has been reported; however, comparison between HbA1c and 1,5-AG as markers of cardiovascular disease was not performed. We included 227 consecutive patients who underwent coronary angiography meeting the following inclusion criteria: (1) patients who had no history of coronary artery disease (CAD); (2) patients without acute coronary syndrome; (3) patients without poorly controlled diabetes mellitus; (4) patients without anemia, liver dysfunction, acute, and chronic renal failure and malnutrition; and (5) patients without adhibition of acarbose or Chinese herbal medicine. We measured HbA1c, glycoalbumin, and 1,5-AG. Serum 1,5-AG was significantly lower in patients with CAD (16.6 ± 8.50 vs. 21.1 ± 7.97 µg/ml, P < 0.001). Multivariable logistic regression analysis showed decrease in serum 1,5-AG was independently associated with the presence of denovo CAD (0.93, 95% CI 0.88-0.98, P = 0.006). Serum 1,5-AG was also independently associated with the presence of denovo CAD in patients without diabetes mellitus (0.94, 95% CI 0.88-0.99, P = 0.046). In conclusion, lower serum 1,5-AG was associated with the presence of denovo CAD. Serum 1,5-AG may identify high cardiovascular risk patients for denovo CAD in both diabetic and non-diabetic patients.


Assuntos
Glicemia/metabolismo , Doença da Artéria Coronariana/sangue , Desoxiglucose/sangue , Diabetes Mellitus/sangue , Hemoglobinas Glicadas/análise , Hiperglicemia/sangue , Idoso , Biomarcadores/sangue , Angiografia Coronária , Feminino , Produtos Finais de Glicação Avançada , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Estudos Prospectivos , Curva ROC , Fatores de Risco , Albumina Sérica , Albumina Sérica Glicada
2.
Immunogenetics ; 65(11): 785-93, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23913278

RESUMO

Approximately 80 proteins are reported to be present in chicken egg white. The major function of egg white proteins isolated so far is to defend the egg yolk against infections. We recently isolated a novel protein termed EW135 from chicken egg white. In this paper, we have determined the complete amino acid sequence of EW135 based on cDNA cloning. EW135 consists of 970 amino acids with a putative signal peptide of 17 amino acids. It is composed exclusively of tandem repeats of nine group B scavenger receptor cysteine-rich (SRCR) domains separated by eight seven-amino acid peptides. The features of consensus sequences found in the group B SRCR domain were well conserved in EW135. The EW135 gene consists of putative 11 exons, with each SRCR domain being encoded by a single exon. Reverse transcription PCR showed that EW135 is expressed in only the oviduct among the 11 types of tissues tested. EW135 is a second soluble protein belonging to the group B SRCR domain superfamily identified in chickens. One of the important functions of proteins belonging to the group B SRCR domain superfamily is to recognize pathogens in innate immunity. It is, therefore, conceivable that EW135 could be involved in host defense in egg white.


Assuntos
Proteínas do Ovo/metabolismo , Genômica , Receptores Depuradores Classe B/metabolismo , Sequência de Aminoácidos , Animais , Sequência de Bases , Galinhas , Clonagem Molecular , Sequência Consenso , Cisteína , DNA Complementar/genética , Proteínas do Ovo/genética , Éxons/genética , Feminino , Íntrons/genética , Dados de Sequência Molecular , Oviductos/citologia , Oviductos/metabolismo , Reação em Cadeia da Polimerase , Estrutura Terciária de Proteína , Receptores Depuradores Classe B/genética , Homologia de Sequência de Aminoácidos , Distribuição Tecidual
3.
J Toxicol Sci ; 37(4): 681-90, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22863849

RESUMO

Delayed effects of exposure to small amounts of estrogenic compounds during the critical period of brain sexual differentiation were investigated by subcutaneous treatment of female Sprague-Dawley rats with 0 (vehicle control), 0.08, 0.4, or 2 µg/kg of 17α-ethynylestradiol (EE) on postnatal day (PND) 1. The treatment did not affect growth and development of the treated animals, and the timings of vaginal opening were similar between the EE-treated and control groups. The animals were periodically examined for the estrous cycle from postnatal week (PNW) 8-9 to PNW 32-33. Patterns of the estrous cycle were similar among the groups until PNW 17. None of the control animals showed persistent estrus until PNW 33. The animals treated with 0.4 µg/kg or more EE showed persistent estrus from PNW 20. The alteration was reflected in the number of days judged as proestrus or estrus, and was found to gradually increase in the EE-treated groups. At necropsy on PNW 32-33, ovulation was not confirmed in most EE-treated animals, even on the day of estrus. In addition, sporadic milk accumulations were observed in the mammary gland of the EE-treated animals. Histological evaluation revealed cystic follicle formation in the EE-treated ovaries and also revealed hyperplasia of mammary glands. Furthermore, ovaries from the animals showing persistent estrus lacked corpus luteum, indicating long-term anovulation. These results clearly show that single exposure to EE during the critical period of brain sexual differentiation can exert effects on reproductive functions at a later period in rats.


Assuntos
Etinilestradiol/toxicidade , Ovulação/efeitos dos fármacos , Efeitos Tardios da Exposição Pré-Natal/tratamento farmacológico , Animais , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Estro/efeitos dos fármacos , Feminino , Tamanho do Órgão/efeitos dos fármacos , Folículo Ovariano/efeitos dos fármacos , Gravidez , Efeitos Tardios da Exposição Pré-Natal/fisiopatologia , Ratos , Ratos Sprague-Dawley , Diferenciação Sexual/efeitos dos fármacos , Vagina/efeitos dos fármacos
4.
Eukaryot Cell ; 3(1): 27-39, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-14871934

RESUMO

We report the identification of Schizosaccharomyces pombe mde10+ as a gene possessing a FLEX element, which forms a binding site for the meiosis-specific transcription factor Mei4. In fact, mde10+ is transcribed only in diploid cells that are induced to meiosis in a Mei4-dependent manner. Western blot analysis indicated that the epitope-tagged Mde10 protein accumulates transiently during meiosis and then rapidly decreases. Mde10 is a multidomain protein containing a metalloprotease catalytic domain, a disintegrin domain, a cysteine-rich domain, and membrane-spanning regions, all of which are shared by members of the mammalian ADAM family. A fusion protein of Mde10 and green fluorescent protein localized to the endoplasmic reticulum during meiosis and was located at the peripheral region of spores at the end of meiosis. An mde10Delta deletion mutant showed no apparent defects in meiosis, sporulation, or spore germination. However, the mutant spores exhibited an aberrant surface appearance, in which the ragged outer spore wall was lost to a large extent. Furthermore, mde10Delta spores were found to be less tolerant to ethanol and diethyl ether than were wild-type spores. The mutagenic replacement of the conserved glutamic acid in the putative protease active site with an alanine residue did not affect the surface morphology or the resistance of spores to environmental stress. Our observations indicate that Mde10 is important in the development of the spore envelope, although this function of Mde10 seems to be independent of its metalloprotease activity.


Assuntos
Proteínas Fúngicas/fisiologia , Metaloproteases/química , Metaloproteases/fisiologia , Proteínas de Schizosaccharomyces pombe/química , Proteínas de Schizosaccharomyces pombe/fisiologia , Schizosaccharomyces/fisiologia , Alanina/química , Alelos , Sequência de Aminoácidos , Sequência de Bases , Sítios de Ligação , Northern Blotting , Southern Blotting , Western Blotting , Domínio Catalítico , Membrana Celular/metabolismo , Centrifugação com Gradiente de Concentração , Cisteína/química , DNA Complementar/metabolismo , Retículo Endoplasmático/metabolismo , Epitopos , Etanol/farmacologia , Éter/farmacologia , Proteínas Fúngicas/metabolismo , Deleção de Genes , Biblioteca Gênica , Genótipo , Proteínas de Fluorescência Verde , Proteínas Luminescentes/metabolismo , Meiose , Microscopia Eletrônica , Microscopia de Fluorescência , Modelos Biológicos , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Mutação , Fases de Leitura Aberta , Plasmídeos/metabolismo , Estrutura Terciária de Proteína , Proteínas Recombinantes de Fusão/metabolismo , Fatores de Tempo , Transcrição Gênica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA